Michael Rynkiewicz
6Patents
4h-index
24Co-inventors
49Inventor score
Filing activity: Apr 2, 2004 → Mar 25, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7217794B2 | Compounds and methods for treatment of thrombosis | Human Necessities | 89 | Expired |
| US7501404B2 | Substituted azetidinones | Chemistry; Metallurgy | 14 | Expired |
| US8343489B2 | Methods for humanizing antibodies and humanized antibodies made thereby | Chemistry; Metallurgy | 7 | Active |
| US8486895B2 | Anti-epidermal growth factor receptor antibodies and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US8653244B2 | Anti-epidermal growth factor receptor antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9028832B2 | Humanized anti-EGFR antibody L4-H3 and coding gene thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.